Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines (Q44305187)

1 December 2017

Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines (English)

1 reference

1 December 2017

0 references

1 reference

Bramson J

1

1 reference

1 December 2017

Dayball K

2

1 reference

1 December 2017

Evelegh C

3

1 reference

1 December 2017

Wan YH

4

1 reference

1 December 2017

Page D

5

1 reference

1 December 2017

Smith A

6

1 reference

1 December 2017

language of work or name

1 reference

1 February 2003

1 reference

1 December 2017

1 reference

1 December 2017

10

1 reference

1 December 2017

3

1 reference

1 December 2017

251-260

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301886

1 December 2017

0 references

cites work

The cutaneous citadel: a holistic view of skin and immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Superiority of the ear pinna over muscle tissue as site for DNA vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Fluorescein kinetics in interstitial fluid harvested from diabetic skin during fluorescein angiography: implications for glucose monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Novel mechanisms and devices to enable successful transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Microfabricated microneedles for gene and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Needle-free, non-adjuvanted skin immunization by electroporation-enhanced transdermal delivery of diphtheria toxoid and a candidate peptide vaccine against hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Coupling and uncoupling of tumor immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Inducing autoimmune disease to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Adenovirus-mediated expression of melanoma antigen gp75 as immunotherapy for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Vaccination onto bare skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Intradermal DNA immunization by using jet-injectors in mice and monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Human adenovirus vectors for gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Immunization via hair follicles by topical application of naked DNA to normal skin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Transcutaneous immunization: a human vaccine delivery strategy using a patch

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301886

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301886

1 reference

1 December 2017

1 reference